The drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a ...

Bloomfield-based The Cigna Group saw its stock fall steeply Thursday morning after its fourth-quarter earnings fell well ...

Inflation, uncertain markets and a limited Social Security COLA are among the financial hurdles for retirees in 2025.

UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a ... according to the data firm FactSet.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Walgreens booked a better-than-expected fiscal first quarter and gave Wall Street some positive vibes on the drugstore ...

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CEO Tim Wentworth told analysts the company has had success modifying contracts with commercial insurers as well as Medicare and Medicaid ... according to FactSet. Walgreens also said Friday ...

UnitedHealth said it was still dealing with an increase in prescriptions for expensive specialty drugs, rate cuts to its federally funded Medicare ... to the data firm FactSet.